Clinical Trial Update: Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer [Phase 3]

View source ↗

Summary

A completed Phase 3 randomized trial evaluating the predictive accuracy of a gene-expression test for Stage I-II breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED